e-SPACE Heart Failure 2023

Published: 25 October 2023

  • Views:

    Views Icon 3135

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Heart Failure 2023.

 

A thoughtfully curated programme supported the exploration of how leading experts are implementing the new heart failure guidelines into clinical practice and showed the latest information on patient profiling in heart failure for tailoring medical therapy.

 

This event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.

 

Click here to watch e-SPACE Heart Failure 2022.
 

e-SPACE Heart Failure 2023 would like to thank the following sponsors:

Learning Objectives

  • Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
  • Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
  • Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
  • Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
  • Translate the findings of recent studies and guidelines into optimal patient management

Target Audience

  • Heart Failure Specialists
  • General Cardiologists
  • General Practitioners (GPs)
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

More from this programme

Part 1

Day One

10 sessions
Plenary session 1 – Recent guideline updates in HF Watch now
Meet the expert – Iron Deficiency & IV Iron – The 2023 ESC HF Guidelines and Recent Trial Results: Interpretation & Implementation (Supported by an unrestricted educational grant from Pharmacosmos) Watch now
Plenary session 2 – GDMT in the clinical setting Watch now
Special Live Interactive Session – Management of ATTR-CM Watch now
Meet the expert – Best practices in the management of patients with cardiac amyloidosis (Supported by an educational grant from AstraZeneca) Watch now
Plenary session 3 – SGLT2i in clinical practice Watch now
Meet the expert – Management of patients with HFpEF: What did we learn from our HFrEF patients (Supported by an educational grant from AstraZeneca) Watch now
Plenary session 4 – Obesity and weight management in HF Watch now
Special Live Interactive Session – Best practices for hyperkalemia management across the cardiorenal spectrum Watch now
Plenary session 5 – Worsening and acute heart failure Watch now

Part 2

Day Two

8 sessions
Meet the expert – Iron deficiency and heart failure – what we have learnt so far? (Supported by an unrestricted educational grant from CSL Vifor) Watch now
Plenary session 6 – Iron deficiency: the totality of evidence Watch now
Meet the expert – Practical approaches in the management of hyperkalemia (Supported by an educational grant from AstraZeneca) Watch now
Plenary session 7 – Managing comorbidities in HF Watch now
Plenary session 8 – Devices in HF: time to reassess their place? Watch now
Meet the expert – What happens if you fix FMR, but ignore the root cause of heart failure? (Supported by an unrestricted educational grant from Cardiac Dimensions) Watch now
Plenary session 9 – New technologies for HF management Watch now
Plenary session 10 – Special Populations Watch now

Faculty Biographies

Stefan Anker

Stefan Anker

Professor of Cardiology

Prof Stefan Anker is professor of (Tissue) Homeostasis in Cardiology & Metabolism at Charité Berlin, Germany, since June 2017. Prodigious researcher who has authored more than 1,000 articles. He has also won several prizes, including the 2018 Copernicus Prize of German DFG & Polish FNP. In October 2020, he was awarded a Doctor honoris causa of Medical University Wroclaw, Poland.

Prof Anker has been serving on the board of the Heart Failure Association (HFA) of the ESC since 2006 and was HFA President from 2012 to 2014. He currently chairs the HFA committee on regulatory affairs. He is founding Editor-in-Chief of the first open-access heart failure journal, ESC Heart Failure. Prof. Anker has served on several ESC Guideline task forces.

Prof Anker is the founding president of the International Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD) and founding Editor-in-Chief of the Journal of Cachexia, Sarcopenia and…

View full profile
Giuseppe Rosano

Giuseppe Rosano

Consultant Cardiologist and Professor of Cardiology (Hon)

Giuseppe Rosano is Consultant Cardiologist and Professor of Cardiology at St George’s, University of London, UK where he is also the director of MSc Heart Failure.

His research interests focus on experimental and clinical pharmacology, heart failure, cardiac metabolism, diabetes and gender differences in cardiovascular diseases. Prof Rosano has been core member of the Cardiovascular Working Party of the European Medicines Agency and member of the Pricing and Reimbursement Committee of the Italian Drug Agency. He is the President-Elect of the Heart Failure Association Board (HFA), and Chairman of the Education Committee of the HFA. Prof Rosano is on the editorial board for European Journal of Heart Failure, European Heart Journal CV Pharmacotherapy, Cardiac Failure Reviews and Cardiovascular Diabetology. He has authored more than 500 peer…

View full profile
Javier de Juan Bagudá

Javier de Juan Bagudá

Clinical Cardiologist

Dr Javier de Juan Bagudá is a Clinical Cardiologist at University Hospital 12 de Octubre, Madrid, ES.

He is a specialist in heart failure, hypertension and ischemic heart disease.

He has participated as Principal Investigator in several multicenter clinical trials and clinical registries.

View full profile
Marat Fudim

Marat Fudim

Assistant Professor

Dr Marat Fudim is a cardiologist, advanced heart failure specialist and assistant professor at Duke University, Durham, US. He has a clinical and research interest in heart failure, including advanced therapies such as mechanical assist devices or "heart pumps" and heart transplantation.

As part of his work, Dr Fudim also performs cardiac catheterizations to understand a patient’s disease. 

View full profile
William T Abraham

William T Abraham

Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine

Prof Abraham is a College of Medicine Distinguished Professor. He has been recognized as one of the “Best Doctors in America” for 18 consecutive years.

His research has led to the approval/adoption of new heart failure therapies, including beta-blockers, natriuretic peptides, cardiac resynchronization therapy, ultrafiltration, implantable hemodynamic monitoring, transvenous phrenic nerve stimulation, cardiac contractility modulation, baroreflex activation therapy, and mitral valve repair.

Prof Abraham has authored more than 1,000 original works and has been named a Clarivate Analytics Highly Cited Researcher and one of The World’s Most Influential Scientific Minds.

He received the 2017 Distinguished Scientist Award from the American College of Cardiology.

With his permission, Prof Abraham is contactable here.

View full profile

Comments

You must be to comment. If you are not registered, you can register here.